A Director at Bellerophon (NASDAQ: BLPH) is Buying Shares

By Carrie Williams

Today, a Director at Bellerophon (BLPHResearch Report), Jonathan Peacock, bought shares of BLPH for $12K.

In addition to Jonathan Peacock, 2 other BLPH executives reported Buy trades in the last month. This recent transaction increases Jonathan Peacock’s holding in the company by 1.08% to a total of $1.16 million.

See today’s analyst top recommended stocks >>

Currently, Bellerophon has an average volume of 239.5K.

Starting in August 2018, BLPH received 10 Buy ratings in a row.

The insider sentiment on Bellerophon has been positive according to 35 insider trades in the past three months. This sentiment is slightly higher than the average sentiment of company insiders in this sector.

Jonathan Peacock’s trades have generated a -51.5% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company, which focuses on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases.